237. Deputy Fiona O'Loughlin asked the Minister for Health the reason for the continued delay in access to medication for persons with multiple sclerosis in view of the fact drugs have recently become available and accessible in other EU countries, for example, siponimod; the steps he will take to expedite access of such drugs for patients; and the timeframe for same. [52036/19]

Summary

237. Deputy Fiona O'Loughlin asked the Minister for Health the reason for the continued delay in access to medication for persons with multiple sclerosis in view of the fact drugs have recently become available and accessible in other EU countries, for example, siponimod; the steps he will take to expedite access of such drugs for patients; and the timeframe for same. [52036/19]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 11 December 2019

   Medicinal Products Availability

   237. Deputy Fiona O'Loughlin asked the Minister for Health the reason for the continued delay in access to medication for persons with multiple sclerosis in view of the fact drugs have recently become available and accessible in other EU countries, for example, siponimod; the steps he will take to expedite access of such drugs for patients; and the timeframe for same. [52036/19]

   Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Availability

  xml · EN · 11 December 2019

  ViewDownloadOpen at official source

Sponsors

• O'Loughlin, Fiona. · Asking member
• Health · Health · Addressed to

Related records

No cross-record relationships stored yet.